Sort
261,768 grants matching “gene therapy”
Apoptosis-Based Cancer Drug Discovery
$1,112,625John C Reed · Sanford Burnham Prebys Medical Discovery Institute · U19 · FY2008 · CA
MD Anderson Cancer Center EDRN- Clinical Validation Center for Early Detection of Ovarian Cancer with a multiple marker algorithm
$1,112,553Robert C Bast · University Of Tx Md Anderson Can Ctr · U01 · FY2025 · CA
MOLECULAR CLASSIFICATION OF B-CELL LYMPHOMA
$1,112,349University Of Nebraska Medical Center · U01 · FY2003 · CA
Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP)
$1,112,296Bruce C Trapnell · Cincinnati Childrens Hosp Med Ctr · R33 · FY2025 · HL
Neuroimaging of Brain Circuits and Neurogenetic Mechanisms in Normal Cognition
$1,112,134Karen Faith Berman · National Institute Of Mental Health · ZIA · FY2014 · MH
The Houston Center for Acquired Resistance Research (H-CARR)
$1,112,099Jeffrey Nicholas Myers · University Of Tx Md Anderson Can Ctr · U54 · FY2024 · CA
Program Project in the Genetics of SLE
$1,112,068Robert P Kimberly · University Of Alabama At Birmingham · P01 · FY2006 · AR
Production of a Gonococcal Vaccine for Countering Antimicrobial Resistance
$1,112,000Anthony Bernard Schryvers · University Of Calgary · R01 · FY2019 · AI
RNA interference-based screens for molecular targets in cancer
$1,111,940Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Molecular diagnosis and outcome prediction in lymphoma
$1,111,940Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Oncogenic mechanisms and molecular targets in lymphoma
$1,111,940Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Immuno/Immuno-Gene Therapies for Thoracic Malignancies
$1,111,842Steven Mark Albelda · University Of Pennsylvania · P01 · FY2013 · CA
ANTIBODY-BASED PROTECTION AGAINST FLAVIVIRUSES
$1,111,778Michael S. Diamond · Washington University · U01 · FY2025 · AI
From genetic association to function: pleiotropic novel genes and variants linking lipid metabolism and cardiovascular diseases
$1,111,752Daniel James Rader · University Of Pennsylvania · R35 · FY2025 · HL
Preclinical evaluation of a potent Lassa fever immunotherapeutic antibody cocktail
$1,111,574Robert F Garry · Tulane University Of Louisiana · R01 · FY2019 · AI
Optimization of Nanoparticle Targeting in Ovarian and Breast Cancer
$1,111,562Tillman Gerngross · Dartmouth College · U54 · FY2010 · CA
Dipyridamole as a Modulator of HIV-1 Inflammation by Adenosine Regulation
$1,111,436Sharon Riddler · University Of Pittsburgh At Pittsburgh · U01 · FY2016 · AI
Preclinical Pulmonary Fibrosis, an opportune rare disease cohort
$1,111,413David Albert Schwartz · University Of Colorado Denver · UH3 · FY2024 · HL
Human Polycystic Kidney Disease
$1,111,406University Of Colorado Denver · P01 · FY2005 · DK
Clinical Research in the NIMH Office of the Clinical Director
$1,111,393Maryland Pao · National Institute Of Mental Health · ZIA · FY2025 · MH
Hepato/Renal Fibrocystic Diseases Core Center (UAB HRFDCC)
$1,111,240Bradley K. Yoder · University Of Alabama At Birmingham · P30 · FY2012 · DK
Hepato/Renal Fibrocystic Diseases Core Center (UAB HRFDCC)
$1,111,239Bradley K. Yoder · University Of Alabama At Birmingham · P30 · FY2011 · DK
Hepato/Renal Fibrocystic Diseases Core Center (UAB HRFDCC)
$1,111,239Bradley K. Yoder · University Of Alabama At Birmingham · P30 · FY2014 · DK
Immunology And Pathology Of Acute and Chronic Murine Leukemia Virus Infections
$1,110,653Kim Hasenkrug · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
NHGRI/DIR Genetic Counseling Training Program
$1,110,553Lori Erby · National Human Genome Research Institute · ZIE · FY2019 · HG